Literature DB >> 35734535

A 16-Year Natural History of a Congenital Pseudoaneurysm of the Mitral-Aortic Intervalvular Fibrosa.

James A Bishara1, Courtney Dobson1.   

Abstract

Pseudoaneurysm of the mitral aortic intervalvular fibrosa is a rare condition most often reported as sequela of endocarditis and surgical trauma, with congenital cases being very uncommon. This case describes a congenital pseudoaneurysm of the mitral aortic intervalvular fibrosa and stable 16-year natural history. (Level of Difficulty: Intermediate.).
© 2022 The Authors.

Entities:  

Keywords:  AOV, aortic valve; MV, mitral valve; PMAIF, pseudoaneurysm of the mitral-aortic intervalvular fibrosa; bicuspid aortic valve; congenital heart disease; echocardiography; mitral valve

Year:  2022        PMID: 35734535      PMCID: PMC9207958          DOI: 10.1016/j.jaccas.2022.05.002

Source DB:  PubMed          Journal:  JACC Case Rep        ISSN: 2666-0849


History of Presentation

A 16-year-old otherwise healthy male patient who was lost to follow-up since 3 years of age presented to reestablish care for a mitral valve (MV) disorder. He was found to have an “aneurysm of the MV” and bicuspid aortic valve (AOV) without stenosis or insufficiency at 2 months of age after being referred for a nonspecific intracardiac finding on a fetal echocardiogram. He remains asymptomatic and participates in competitive track and golf with a negative review of systems. His physical exam revealed bradycardia with a rate of 43 beats/min, otherwise normal vital signs, and a nonspecific 2/6 midsystolic ejection murmur heard equally at the right and left upper sternal borders without radiation.

Learning Objectives

To develop a differential diagnosis for aneurysmal lesions of the MV. To understand the how the natural history of PMAIF differs based on etiology. His initial evaluation consisted of a transthoracic echocardiogram followed by a transesophageal echocardiogram (Figures 1A, 2A, and 3A, Video 1). He was started on aspirin after those evaluations but was discontinued due to a rash. He was followed until 3 years of age on no medications before being lost to follow-up.
Figure 1

Comparison of Long Axis

Comparison of parasternal long-axis view demonstrating the aortic valve and mitral valve with the pseudoaneurysm (arrow) seen within the left atrium (LA) posterior to the anterior leaflet of the mitral valve. (A) Two months of age. (B) Sixteen years of age. LV = left ventricle.

Figure 2

Comparison of Apical 4-Chamber

Comparison of an apical 4-chamber view demonstrating the pseudoaneurysm (arrow) seen within the LA. (A) Two months of age. (B) Sixteen years of age. Ao = aorta; other abbreviations as in Figure 1.

Figure 3

Comparison of Short Axis

Comparison of parasternal short-axis view showing the spherical pseudoaneurysm (arrow) toward the left and irregular tissue adjacent that extends along the underside of the atrial reflection of the aortic root. (A) Two months of age. (B) Sixteen years of age. RA = right atrium; RV = right ventricle.

Comparison of Long Axis Comparison of parasternal long-axis view demonstrating the aortic valve and mitral valve with the pseudoaneurysm (arrow) seen within the left atrium (LA) posterior to the anterior leaflet of the mitral valve. (A) Two months of age. (B) Sixteen years of age. LV = left ventricle. Comparison of Apical 4-Chamber Comparison of an apical 4-chamber view demonstrating the pseudoaneurysm (arrow) seen within the LA. (A) Two months of age. (B) Sixteen years of age. Ao = aorta; other abbreviations as in Figure 1. Comparison of Short Axis Comparison of parasternal short-axis view showing the spherical pseudoaneurysm (arrow) toward the left and irregular tissue adjacent that extends along the underside of the atrial reflection of the aortic root. (A) Two months of age. (B) Sixteen years of age. RA = right atrium; RV = right ventricle.

Past Medical History

He was born full term without complications and has no history of hospitalizations, surgeries, serious illness, or chronic medical problems except the previously mentioned cardiac history.

Differential Diagnosis

The differential diagnosis included a congenital cystic defect of the MV, an aortic pseudoaneurysm entering the left atrium, and a pseudoaneurysm of the mitral-aortic intervalvular fibrosa (PMAIF).

Investigations

Transthoracic echocardiography showed a sac originating in the mitral-aortic intervalvular fibrosa (Figures 1B, 2B, and 3B). There is a 1.3-cm initially spherical-appearing aneurysm seated on the fibrosa of the anterior leaflet of the MV that communicates with to-fro flow with the left ventricular outflow tract through a 0.4-cm orifice (Figures 1B and 2B,Videos 2 and 3). Tissue from the pseudoaneurysm extends along the left atrial reflection of the aortic root toward and along the atrial septum (Figure 3B, Video 4). The right nonfused bicuspid AOV continued to be free of insufficiency, prolapse, or stenosis. The MV has trace regurgitation, but has no prolapse or stenosis. The remainder of the cardiac anatomy is normal, as are systolic and diastolic function. There is no suggestion of thrombus formation or endocarditis. When compared with both the initial and most recent prior echocardiogram performed at 2 months of age and 3 years of age, the pseudoaneurysm is grossly unchanged in appearance (Figures 1, 2, and 3). There has been an increase in absolute size that appears consistent with somatic growth. The proportions of the pseudoaneurysm relative to other cardiac structures appears unchanged. A 12-lead electrocardiogram demonstrated a prolonged PR interval of 236 ms in the setting of a marked sinus bradycardia (35 beats/min). A 48-hour Holter monitor was obtained because demonstrated sinus bradycardia with an average rate of 44 beats/min, maximum of 135 beats/min, and minimum of 22 beats/min while sleeping with rare premature atrial contractions (<0.1%). There was neither a second- or third-degree block nor other arrhythmias. He did not have an electrocardiogram during his initial assessment.

Management

The stable appearance of the aneurysm for over a decade, normal ventricular and valve function, and the lack of symptoms allowed for observation of this lesion. We recommended against heavy weightlifting, but the patient was otherwise allowed to continue participating in sports and takes no medications. We had concerns that any surgical solution could potentially damage the atrioventricular node, placing him at risk for advanced heart block in addition to other risks of surgery, most specifically AOV and MV dysfunction. Aspirin was considered as an antithrombotic prophylaxis, but because of his history of a possible reaction, no evidence of thrombus formation for over a decade while off therapy, and his active lifestyle, we elected against aspirin or other antiplatelet agent. Spontaneous bacterial endocarditis prophylaxis was recommended.

Discussion

PMAIF is most commonly seen as a complication of endocarditis and surgical trauma in patients with a bicuspid AOV., Only rare congenital cases have been reported.3, 4, 5 Cases of acquired PMAIF usually undergo operative repair because the lesion causes valve dysfunction and is at risk of expansion, rupture, and thrombus formation. In contrast, congenital cases may not have the same risk as PMIAF from acquired causes. Del Pasqua et al reported a stable 5-year natural history of a congenital PMAIF without any significant change in appearance. Similarly, Harrington et al reported a stable 1-year natural history of a prenatally diagnosed PMIAF. Caution should be used when describing the case as congenital or acquired, which may imply a different natural history. Lizano Santamaria et al reported a case of a PMIAF in a 4-year-old related to culture-negative AOV endocarditis, and He et al reported a case in a 5-year-old that developed several years after a ventricular septal defect repair. In both cases, the term congenital was applied despite the most likely cause being endocarditis and cardiac surgery, respectively. In both cases, there were sequelae that supported surgical intervention. We believe the term congenital should only be applied to those without a history of intracardiac surgery, infective endocarditis, or other process that could mechanically disrupt the fibrosa. Our case is the longest reported natural history of PMAIF, with a similar stable course described by Harrington et al and Del Pasqua et al. It is reasonable to conclude that the natural history of congenital PMAIF can be stable and does not necessitate immediate surgery in the absence of symptoms or other concerning findings. We would consider a surgical option if there was valve dysfunction secondary to the aneurysm, thrombus formation, increasing size, pulmonary venous or mitral inflow obstruction, or concerns about compression of any part of the left coronary system. Given the limited information on the natural history, offering surgery in the asymptomatic patient could be considered to reduce the hypothetical risk of endocarditis, thrombus, and rupture. In this case, the risk for surgical heart block is not insignificant. We suspect that the first-degree heart block in our case is from aneurysmal damage to the atrioventricular node. If our patient developed advanced heart block, surgery would be considered. We propose the sinus bradycardia is from athletic conditioning and high vagal tone unrelated to the PMAIF.

Follow-Up

Serial echocardiograms, electrocardiograms, and Holter monitors are planned every 2 years.

Conclusions

Congenital PMAIF is a rare finding that in the absence of symptoms can be conservatively managed without surgery. We believe the term congenital should be applied to those patients without a history of intracardiac procedure or suspicion of endocarditis. Aspirin can be considered for thrombus prophylaxis, but the benefit of this therapy is unclear.

Funding Support and Author Disclosures

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
  6 in total

1.  Congenital pseudoaneurysm of the mitral-aortic intervalvular fibrosa with a 5 years' follow up.

Authors:  A Del Pasqua; Claudia Esposito; Priscilla Milewski; Paolo Ciliberti; Marcello Chinali; Aurelio Secinaro; Gabriele Rinelli
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-08       Impact factor: 2.357

Review 2.  Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (MAIVF): A comprehensive review.

Authors:  Selvin Sudhakar; Asif Sewani; Mayank Agrawal; Barry F Uretsky
Journal:  J Am Soc Echocardiogr       Date:  2010-10       Impact factor: 5.251

3.  Congenital aneurysm of the aortomitral intervalvular fibrosa.

Authors:  Dingchao He; Pranava Sinha; Laura Olivieri; Richard A Jonas
Journal:  Ann Thorac Surg       Date:  2015-01       Impact factor: 4.330

4.  Congenital pseudoaneurysm of the mitral-aortic intervalvular fibrosa: a case report.

Authors:  Jamie K Harrington; Julie Glickstein; Amee Shah
Journal:  Cardiol Young       Date:  2017-05-29       Impact factor: 1.093

5.  Congenital pseudoaneurysm of mitral-aortic intervalvular fibrosa masquerading as left atrial mass in fetal life.

Authors:  Shanthi Chidambarathanu; Vijayalakshmi Raja; Indrani Suresh
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

6.  Unusual Presentation of Congenital Pseudoaneurysm of Mitral Aortic Intervalvular Fibrosa in a Healthy Child.

Authors:  Ramiro W Lizano Santamaria; Edward J Hickey; Christoph Haller; Vitor C Guerra
Journal:  CASE (Phila)       Date:  2018-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.